Decoding the revolution of total arterial coronary artery bypass graft surgery
Authors
- Redoy RanjanDepartment of Cardiac Surgery, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh https://orcid.org/0000-0003-1927-5023
- Aziz MominDepartment of Cardiac Surgery, St George’s University Hospital NHS Foundation Trust, London, United Kingdom
DOI:
https://doi.org/10.3329/bsmmuj.v18i1.76295Keywords
Downloads
Correspondence
Publication history
Responsible editor
Reviewers
Funding
Ethical approval
Trial registration number
Copyright
Published by Bangabandhu Sheikh
Mujib Medical University
Despite the compelling advantages of TA-CABG, widespread adoption was hindered by various factors, especially a lack of surgical expertise, technical challenges, and concerns regarding long-term graft patency. However, recent initiatives, including training programmes and international collaborations, have highlighted the benefits of arterial conduits due to physiology and structural resilience, preserved endothelial function, and resistance to graft disease in real-world scenarios. Moreover, the time has come to wholeheartedly embrace the innovative TA-CABG approach to advance arterial revascularisation and optimise patient clinical outcomes. Finally, preserving venous conduits for potential future interventions is highly recommended, especially in patients who may require multiple revascularisation procedures.
Categories | Number (%) |
Sex |
|
Male | 36 (60.0) |
Female | 24 (40.0) |
Age in yearsa | 8.8 (4.2) |
Education |
|
Pre-school | 20 (33.3) |
Elementary school | 24 (40.0) |
Junior high school | 16 (26.7) |
Cancer diagnoses |
|
Acute lymphoblastic leukemia | 33 (55) |
Retinoblastoma | 5 (8.3) |
Acute myeloid leukemia | 4 (6.7) |
Non-Hodgkins lymphoma | 4 (6.7) |
Osteosarcoma | 3 (5) |
Hepatoblastoma | 2 (3.3) |
Lymphoma | 2 (3.3) |
Neuroblastoma | 2 (3.3) |
Medulloblastoma | 1 (1.7) |
Neurofibroma | 1 (1.7) |
Ovarian tumour | 1 (1.7) |
Pancreatic cancer | 1 (1.7) |
Rhabdomyosarcoma | 1 (1.7) |
aMean (standard deviation) |
Categories | Number (%) |
Sex |
|
Male | 36 (60.0) |
Female | 24 (40.0) |
Age in yearsa | 8.8 (4.2) |
Education |
|
Pre-school | 20 (33.3) |
Elementary school | 24 (40.0) |
Junior high school | 16 (26.7) |
Cancer diagnoses |
|
Acute lymphoblastic leukemia | 33 (55) |
Retinoblastoma | 5 (8.3) |
Acute myeloid leukemia | 4 (6.7) |
Non-Hodgkins lymphoma | 4 (6.7) |
Osteosarcoma | 3 (5) |
Hepatoblastoma | 2 (3.3) |
Lymphoma | 2 (3.3) |
Neuroblastoma | 2 (3.3) |
Medulloblastoma | 1 (1.7) |
Neurofibroma | 1 (1.7) |
Ovarian tumour | 1 (1.7) |
Pancreatic cancer | 1 (1.7) |
Rhabdomyosarcoma | 1 (1.7) |
aMean (standard deviation) |